Description
Buy HHC-P Online | Secured Tracked Logistics EU
Order High-Purity HHC-P for Laboratory Research
Technical Specifications & Product Identification Data
-
- Systematic IUPAC Nomenclature: (6aR,10aR)-9-methyl-3-heptyl-6a,7,8,9,10,10a-hexahydrobenzo[c]chromen-1-ol
- Standard CAS Registry Number: 53822-32-5 (Free Base Form)
- Molecular Formula: C₂₃H₃₆O₂ (Refined Hydrogenated Distillate/Powder Form)
- Exact Molar Mass: 344.54 g/mol
- Physical Presentation: Amber, ultra-viscous high-purity resin distillate or processed stable powder amorphous mass
- Structural Classification: Semi-synthetic cannabinoid derivative featuring a fully hydrogenated hexahydrocannabinol core extended explicitly with a seven-carbon (heptyl) alkyl side chain backbone.
Theoretical Pharmacology & Documented Adverse Effects
Legal Status & European Regulations
-
- European Union (EU-Wide Prohibition): Following comprehensive safety assessments and strict regulatory amendments, HHC-P (Hexahydrocannabiphorol) is strictly controlled or scheduled as an illegal substance across the majority of EU Member States. National frameworks—such as Germany’s updated NpSG structural laws and equivalent narcotic lists in France, Italy, and Central Europe—restrict distribution solely to state-authorized scientific installations holding specialized government permits.
- United Kingdom: Strictly prohibited under the Psychoactive Substances Act 2016, criminalizing all forms of unauthorized supply, domestic transfer, or importation into British territory.
- Shipping Policy: Orders addressed to private residential zip codes or unauthorized territories will be delivered securely and discretely at you risk and responsibility
Authorized Research Use & Safety Warning
Frequently Asked Questions (FAQ)
As an ultra-potent CB₁ receptor agonist, exposure to HHC-P carries substantial psychological and physiological risks. Documented adverse reactions include severe hypertensive/tachycardic strain, intense panic reactions, prolonged cognitive impairment, and severe spatial disorientation.
The molecular structure of HHC-P differs from basic HHC solely by its carbon chain length. While traditional HHC features a standard five-carbon (pentyl) tail, HHC-P incorporates an extended seven-carbon (heptyl) side chain, which vastly amplifies its lipophilicity and its binding capacity at active cannabinoid receptors.
No. This compound is synthesized and handled strictly as an analytical reference standard. It is not approved for human or veterinary consumption, and any such application is completely illegal and carries life-threatening health and legal consequences.
